Mirae Asset Global Investments
CGON icon

Mirae Asset Global Investments’s CG Oncology CGON Stock Holding History

Mirae Asset Global Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Sell
3,945
-459
-10% -$30K ﹤0.01% 1070
2026
Q1 		$298K Buy
4,404
+484
+12% +$27.4K ﹤0.01% 1014
2025
Q4 		$163K Buy
3,920
+972
+33% +$40.2K ﹤0.01% 1181
2025
Q3 		$119K Buy
2,948
+3
+0.1% +$87 ﹤0.01% 1184
2025
Q2 		$76.6K Buy
2,945
+398
+16% +$9.59K ﹤0.01% 1183
2025
Q1 		$67.3K Buy
2,547
+293
+13% +$8.24K ﹤0.01% 1186
2024
Q4 		$67.7K Buy
+2,254
New +$77.1K ﹤0.01% 1214

Other funds holding CGON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments's CGON Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its CG Oncology (CGON) stake by 10% in Q2 2026, selling an estimated $30K and leaving 3,945 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #1070.

Mirae Asset Global Investments first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. The position peaked at $298K in Q1 2026. 74 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Mirae Asset Global Investments held 3,945 shares of CG Oncology worth $280K as of Q2 2026.
  • Mirae Asset Global Investments sold 459 CG Oncology shares in Q2 2026, an estimated $30K.
  • CG Oncology made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1070 holding.
  • Mirae Asset Global Investments first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's CG Oncology position peaked at $298K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.